2025

Kardium announces 1-year PULSAR IDE study results for its PFA device – the Globe® PF System

04/25/2025

Vancouver, BC – April 25, 2025 — Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm […]